Your browser doesn't support javascript.
loading
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers.
Sulaiman, Raed; De, Pradip; Aske, Jennifer C; Lin, Xiaoqian; Dale, Adam; Koirala, Nischal; Gaster, Kris; Espaillat, Luis Rojas; Starks, David; Dey, Nandini.
Afiliação
  • Sulaiman R; Department of Pathology, Avera Cancer Institute, Sioux Falls, SD 57105, USA.
  • De P; Translational Oncology Laboratory, Avera Research Institute, Sioux Falls, SD 57105, USA.
  • Aske JC; Department of Internal Medicine, University of South Dakota SSOM, USD, Sioux Falls, SD 57105, USA.
  • Lin X; Translational Oncology Laboratory, Avera Research Institute, Sioux Falls, SD 57105, USA.
  • Dale A; Translational Oncology Laboratory, Avera Research Institute, Sioux Falls, SD 57105, USA.
  • Koirala N; Translational Oncology Laboratory, Avera Research Institute, Sioux Falls, SD 57105, USA.
  • Gaster K; Translational Oncology Laboratory, Avera Research Institute, Sioux Falls, SD 57105, USA.
  • Espaillat LR; Assistant VP Outpatient Cancer Clinics, Avera Cancer Institute, Sioux Falls, SD 57105, USA.
  • Starks D; Department of Gynecologic Oncology, Avera Cancer Institute, Sioux Falls, SD 57105, USA.
  • Dey N; Department of Gynecologic Oncology, Avera Cancer Institute, Sioux Falls, SD 57105, USA.
Biomedicines ; 11(1)2023 Jan 01.
Article em En | MEDLINE | ID: mdl-36672620
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article